Approval · Notice of Compliance 11693 · 2010
LUTREPULSE: Notice of Compliance 11693
Issued August 27, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11693
- Date
- August 27, 2010
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Reactivation of the 3.2 mg strength
- Therapeutic class
- Ovulatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUTREPULSE | 02046202 | Dormant |
Medicinal ingredients
- GONADORELIN ACETATE 3.2 MG per VIAL